MU
Mirova US’s Eli Lilly LLY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $308M | Sell |
395,255
-215,500
| -35% | -$168M | 3.19% | 12 |
|
2025
Q1 | $504M | Buy |
610,755
+20,834
| +4% | +$17.2M | 5.99% | 4 |
|
2024
Q4 | $455M | Sell |
589,921
-18,023
| -3% | -$13.9M | 5.46% | 4 |
|
2024
Q3 | $539M | Buy |
607,944
+5,015
| +0.8% | +$4.44M | 6.18% | 4 |
|
2024
Q2 | $546M | Buy |
602,929
+12,634
| +2% | +$11.4M | 6.8% | 3 |
|
2024
Q1 | $459M | Sell |
590,295
-10,671
| -2% | -$8.3M | 6.17% | 5 |
|
2023
Q4 | $350M | Sell |
600,966
-89,499
| -13% | -$52.2M | 5.28% | 9 |
|
2023
Q3 | $371M | Buy |
690,465
+26,151
| +4% | +$14M | 6.29% | 7 |
|
2023
Q2 | $312M | Buy |
664,314
+16,207
| +3% | +$7.6M | 5.19% | 9 |
|
2023
Q1 | $223M | Buy |
648,107
+7,556
| +1% | +$2.59M | 4.04% | 12 |
|
2022
Q4 | $234M | Sell |
640,551
-197,584
| -24% | -$72.3M | 4.71% | 9 |
|
2022
Q3 | $271M | Sell |
838,135
-3,572
| -0.4% | -$1.16M | 6.33% | 4 |
|
2022
Q2 | $273M | Buy |
841,707
+50,381
| +6% | +$16.3M | 5.88% | 6 |
|
2022
Q1 | $227M | Buy |
791,326
+62,343
| +9% | +$17.9M | 4.35% | 12 |
|
2021
Q4 | $201M | Buy |
728,983
+152,493
| +26% | +$42.1M | 3.78% | 12 |
|
2021
Q3 | $133M | Buy |
576,490
+62,815
| +12% | +$14.5M | 3.11% | 14 |
|
2021
Q2 | $118M | Buy |
513,675
+58,796
| +13% | +$13.5M | 3.16% | 13 |
|
2021
Q1 | $85M | Buy |
+454,879
| New | +$85M | 2.96% | 14 |
|